Sextant Core Fund NVO Holdings History
Sextant Core Fund's Novo Nordisk AS Holding Summary
As of 2025-02-28, SATURNA INVESTMENT TRUST held 5,000.00 shares of Novo Nordisk AS(NVO), totaling $453,250.00. This investment constitutes 2.82% of their stock portfolio, and SATURNA INVESTMENT TRUST now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2022Q1. And since then Sextant Core Fund has made 2 purchases of NVO, at an average price of $57.52, for a total of 7,600.00 shares. In addition, there have been 4 sales at an average price of $97.98 for 2,600.00 shares. Based on historical transaction data and NVO's current price of $70.73, Sextant Core Fund's estimated gain on his NVO holdings is $171,221.00, reflecting a 39.17% gain to date.
Sextant Core Fund NVO ($70.73) Holding Chart
Sextant Core Fund NVO ($70.73) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
